ETPrime

Wockhardt Share Price

  • 1,270.0045.71 (3.74%)
  • Volume: 4,94,997
  • Closed
  • Last Updated On: 12 May, 2025, 03:47 PM IST
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Wockhardt Share Price
  • 1,270.0045.71 (3.74%)
  • Volume: 4,94,997
Advertisment
Stock Recommendations

No Recommendations details available for this stock.

Check Other Recommendations
Stock Reports Plus

/10

Stock Score

View Report
Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

Wockhardt share price insights

View All

  • Company has reported a negative ROE for 3 consecutive years. (Source: Consolidated Financials)

  • Company has posted a profit of Rs 14.0 cr in Dec 31, 2024 quarter after 3 consecutive quarter of losses. (Source: Consolidated Financials)

  • Stock gave a 3 year return of 431.38% as compared to Nifty Midcap 100 which gave a return of 93.2%. (as of last trading session)

  • Company has spent 10.9% of its operating revenues towards interest expenses and 22.48% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

  • Wockhardt Ltd. share price moved up by 3.74% from its previous close of Rs 1,224.30. Wockhardt Ltd. stock last traded price is 1,270.00

    Share PriceValue
    Today/Current/Last1,270.00
    Previous Day1,224.301,227.95

InsightsWockhardt

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		-108.04
    EPS - TTM
    (₹)    		-11.75
    MCap
    (₹ Cr.)    		20,635.67
    Sectoral MCap Rank
    		23
    PB Ratio
    (x)    		5.43
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		5.00
    Beta

    Beta

    1 Month1.27
    3 Months1.79
    6 Months1.76
    1 Year1.71
    3 Years1.57

    		1.27
    VWAP
    (₹)    		1,274.51
    52W H/L
    (₹)
    1,679.90 / 490.15

    Wockhardt Share Price Returns

    1 Day3.74%
    1 Week-1.92%
    1 Month-3.73%
    3 Months-16.01%
    1 Year139.13%
    3 Years451.22%
    5 Years419.43%

    ET Stock ScreenersTop Score Companies

    Check whether Wockhardt belongs to analysts' top-rated companies list?

    View Stock Screeners

    Wockhardt News & Analysis

    View all Wockhardt Share News & Announcements

    Wockhardt Share Recommendations

    • Target₹280
    • OrganizationPrabhudas Lilladher
    • BUY
    • Target₹260
    • OrganizationSharekhan by BNP Paribas
    • BUY
    • Target₹400
    • OrganizationLKP Securities
    • BUY
    View all Recommendations

    Wockhardt Financials

    • Insights

      • PAT: Entering the Green

        Company has posted a profit of Rs 14.0 cr in Dec 31, 2024 quarter after 3 consecutive quarter of losses. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent 10.9% of its operating revenues towards interest expenses and 22.48% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
      Total Income729.00818.00769.00754.00709.00
      Total Income Growth (%)-10.886.371.996.35-8.75
      Total Expenses648.00754.00702.00861.00719.00
      Total Expenses Growth (%)-14.067.41-18.4719.75-2.31
      EBIT81.0064.0067.00-107.00-10.00
      EBIT Growth (%)26.56-4.48---124.39
      Profit after Tax (PAT)14.00-22.00-14.00-169.00-83.00
      PAT Growth (%)-----
      EBIT Margin (%)11.117.828.71-14.19-1.41
      Net Profit Margin (%)1.92-2.69-1.82-22.41-11.71
      Basic EPS (₹)0.91-1.47-0.95-11.64-5.75
      Quarterly | AnnualDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
      Total Income331.00381.00379.00379.00293.00
      Total Income Growth (%)-13.120.530.0029.3510.15
      Total Expenses305.00364.00315.00446.00306.00
      Total Expenses Growth (%)-16.2115.56-29.3745.75-2.55
      EBIT26.0017.0064.00-67.00-13.00
      EBIT Growth (%)52.94-73.44---
      Profit after Tax (PAT)-22.00-36.006.00-126.00-74.00
      PAT Growth (%)--700.00---
      EBIT Margin (%)7.854.4616.89-17.68-4.44
      Net Profit Margin (%)-6.65-9.451.58-33.25-25.26
      Basic EPS (₹)-1.40-2.340.39-8.71-5.14
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue2,881.002,773.003,250.002,840.572,882.80
      Total Revenue Growth (%)3.89-14.6814.41-1.46-31.02
      Total Expenses3,287.003,103.003,478.003,266.433,224.84
      Total Expenses Growth (%)5.93-10.786.481.29-28.01
      Profit after Tax (PAT)-463.00-559.00-244.00686.06-69.22
      PAT Growth (%)---135.57--
      Operating Profit Margin (%)-3.60-1.052.19-6.52-2.33
      Net Profit Margin (%)-16.54-21.08-7.5525.33-2.43
      Basic EPS (₹)-32.05-38.79-20.2461.95-6.25
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue1,195.001,139.001,410.001,027.99933.08
      Total Revenue Growth (%)4.92-19.2237.1610.17-57.22
      Total Expenses1,603.001,417.001,594.001,509.281,416.76
      Total Expenses Growth (%)13.13-11.105.616.53-39.88
      Profit after Tax (PAT)-422.00-466.00-140.00593.29-231.12
      PAT Growth (%)---123.60--
      Operating Profit Margin (%)-14.81-4.576.48-28.46-29.60
      Net Profit Margin (%)-36.56-43.47-10.2060.09-25.96
      Basic EPS (₹)-29.27-32.40-11.6253.57-20.88

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets7,649.007,683.008,243.007,772.698,178.91
      Total Assets Growth (%)-0.44-6.796.05-4.974.44
      Total Liabilities3,987.004,021.004,041.004,012.445,121.45
      Total Liabilities Growth (%)-0.85-0.490.71-21.6511.52
      Total Equity3,662.003,662.004,202.003,760.253,057.46
      Total Equity Growth (%)0.00-12.8511.7522.991.76
      Current Ratio (x)0.780.640.810.780.69
      Total Debt to Equity (x)0.630.560.480.460.80
      Contingent Liabilities995.46881.26868.00567.64641.08
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets4,868.004,732.005,798.004,894.904,759.51
      Total Assets Growth (%)2.87-18.3918.452.844.89
      Total Liabilities3,072.002,979.003,586.003,289.143,764.89
      Total Liabilities Growth (%)3.12-16.939.03-12.6422.35
      Total Equity1,796.001,753.002,212.001,605.76994.62
      Total Equity Growth (%)2.45-20.7537.7561.44-18.91
      Current Ratio (x)0.940.560.780.710.70
      Total Debt to Equity (x)1.000.920.720.831.41
      Contingent Liabilities935.46898.2625.00577.941,511.84

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 137.0 cr for investing activities which is an YoY increase of 9.6%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities219.00153.00413.00-287.32648.96
      Net Cash used in Investing Activities-137.00-125.00-201.001,470.10-155.53
      Net Cash flow from Financing Activities334.00-315.00-71.00-1,170.82-679.58
      Net Cash Flow415.00-280.00138.0012.91-178.00
      Closing Cash & Cash Equivalent505.0090.00370.00232.25219.34
      Closing Cash & Cash Equivalent Growth (%)461.11-75.6859.315.89-44.80
      Total Debt/ CFO (x)9.6412.334.51-5.463.30
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities188.0071.00-93.00-563.97221.51
      Net Cash used in Investing Activities-75.00-3.00-244.001,014.34-16.15
      Net Cash flow from Financing Activities346.00-236.00430.00-479.85-273.97
      Net Cash Flow459.00-168.0093.00-29.48-68.61
      Closing Cash & Cash Equivalent463.004.00172.0078.98108.46
      Closing Cash & Cash Equivalent Growth (%)0.00-97.67117.78-27.18-38.75
      Total Debt/ CFO (x)9.5222.82-17.10-2.356.32

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Losing Shareholder's Money

        Company has reported a negative ROE for 3 consecutive years. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)-13.78-16.66-6.3320.31-2.59
      Return on Capital Employed (%)-2.07-0.651.40-3.79-1.41
      Return on Assets (%)-6.05-7.27-2.968.82-0.84
      Interest Coverage Ratio (x)0.400.741.06-0.71-0.24
      Asset Turnover Ratio (x)0.360.330.2034.8434.77
      Price to Earnings (x)-19.42-3.97-15.586.69-27.70
      Price to Book (x)2.680.660.991.360.72
      EV/EBITDA (x)89.1219.2317.6390.2826.45
      EBITDA Margin (%)4.368.419.842.555.54
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)-23.49-26.58-6.3236.94-23.23
      Return on Capital Employed (%)-5.73-2.323.23-12.26-10.73
      Return on Assets (%)-8.66-9.84-2.4112.12-4.85
      Interest Coverage Ratio (x)0.020.600.95-0.48-1.20
      Asset Turnover Ratio (x)0.240.200.260.2018.70
      Price to Earnings (x)-21.32-4.76-27.177.74-8.28
      Price to Book (x)5.001.261.722.861.92
      EV/EBITDA (x)2,058.1327.7419.93-59.58-35.02
      EBITDA Margin (%)0.4312.7718.95-9.82-10.12

    Financial InsightsWockhardt

    • Income (P&L)
    • Cash Flow
    • Ratios

      • PAT: Entering the Green

        Company has posted a profit of Rs 14.0 cr in Dec 31, 2024 quarter after 3 consecutive quarter of losses. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent 10.9% of its operating revenues towards interest expenses and 22.48% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 137.0 cr for investing activities which is an YoY increase of 9.6%. (Source: Consolidated Financials)

      • Losing Shareholder's Money

        Company has reported a negative ROE for 3 consecutive years. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Wockhardt Technicals

    • Bullish / Bearish signals for Wockhardt basis selected technical indicators and moving average crossovers.

      Stochastic Crossover

      Bearish signal on weekly chart

      Appeared on: 9 May 2025

      Region: Equlibrium

      Last 4 Sell Signals:11 Apr 2025
      Date7 weeks Gain/Loss %
      11 Apr 20250.75%
      14 Feb 2025-19.86%
      10 Jan 2025-16.07%
      20 Dec 2024-4.23%

      Average price decline of -10.82% within 7 weeks of Bearish signal in last 10 years

    • 43%
      Positive Movement since
      1st Jan 2005 on basis
      56%
      Negative Movement since
      1st Jan 2005 on basis
      Exclude

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic1248.431272.571323.871221.271197.131169.971118.67

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR63.2769.5071.75

    Wockhardt Peer Comparison

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of 431.38% as compared to Nifty Midcap 100 which gave a return of 93.2%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 431.38% return as compared to Nifty Pharma which gave investors 67.29% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Midcap 100

            Stock gave a 3 year return of 431.38% as compared to Nifty Midcap 100 which gave a return of 93.2%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 431.38% return as compared to Nifty Pharma which gave investors 67.29% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Wockhardt-108.045.64-13.78-2.07-6.050.47-3.60-16.86-32.050.780.639.64
          Ajanta Pharma33.698.1824.2830.1018.3511.0026.0219.8073.562.850.000.00
          Piramal Pharma722.523.550.225.760.118.727.72-0.500.141.250.584.54
          Suven Pharma 96.9413.2014.6419.2413.322.8039.2928.5611.8011.820.020.11
          Syngene Int.50.755.3310.4912.617.3011.6918.6913.6212.351.640.030.10
          Add More
          Annual Ratios (%)

          Choose from Peers

          • J B Chemicals
          • Gland Pharma
          • Emcure Pharmaceuticals Ltd.
          • Eris Lifesciences
          • Concord Biotech Ltd.

          Choose from Stocks

            See All Parameters

          Peers InsightsWockhardt

          • Stock Returns vs Nifty Midcap 100

            Stock gave a 3 year return of 431.38% as compared to Nifty Midcap 100 which gave a return of 93.2%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 431.38% return as compared to Nifty Pharma which gave investors 67.29% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Wockhardt Shareholding Pattern

          • Loading...
            Showing Wockhardt Shareholding as on Mar 2025
            CategoryMar 2025Dec 2024Sep 2024Jun 2024
            Promoters49.0949.0951.9951.99
            Pledge18.2416.9833.6437.47
            FII6.826.546.705.93
            DII10.579.805.084.45
            Mutual Funds7.567.132.952.91
            Others33.5134.5636.2337.62
          • Showing Shareholding as on Mar 2025
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters7,97,58,84849.09 %0.00
            Pledge1,45,46,88218.24 %1.25
            FII1,10,68,6856.82 %0.28
            DII1,71,95,28010.57 %0.76
            MF1,22,90,2247.56 %0.42
            Others5,44,62,75633.51 %-1.04

          Wockhardt MF Ownership

          MF Ownership as on 31 March 2025

          View all Mutual Fund Schemes
          Top Searches:
          Wockhardt News Wockhardt Quarterly Results Wockhardt Dividend Wockhardt Q1 ResultsWockhardt Q2 ResultsWockhardt Q3 ResultsWockhardt Q4 Results

          Wockhardt Corporate Actions

          • Meeting DateAnnounced onPurposeDetails
            Feb 07, 2025Feb 03, 2025Board MeetingQuarterly Results
            Nov 13, 2024Nov 08, 2024Board MeetingQuarterly Results
            Aug 09, 2024Aug 05, 2024Board MeetingQuarterly Results
            Jun 28, 2024Jun 06, 2024AGM-
            May 28, 2024May 21, 2024Board MeetingAudited Results
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Interim200%10.0Nov 17, 2016Oct 28, 2016
            Final0%5.0E-4Aug 04, 2016May 06, 2016
            Interim400%20.0Nov 13, 2014Nov 03, 2014
            Interim100%5.0Feb 17, 2014Feb 10, 2014
            Interim100%5.0Nov 07, 2013Oct 25, 2013
          • All TypesEx-DateRecord DateAnnounced onDetails
            RightsMar 08, 2022Mar 09, 2022Jan 06, 2022Rights ratio: 3 share for every 10 held at a price of Rs 225.0
            SplitsApr 28, 2004-Feb 12, 2004Split: Old FV10.0| New FV:5.0
            BonusApr 28, 2004-Feb 12, 2004Bonus Ratio: 1 share(s) for every 2 shares held
            Bonus-Jan 24, 1995Jan 24, 1995Bonus Ratio: 1 share(s) for every 1 shares held

          About Wockhardt

          Wockhardt Ltd., incorporated in the year 1999, is a Mid Cap company (having a market cap of Rs 19,893.11 Crore) operating in Pharmaceuticals sector. Wockhardt Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Export Incentives for the year ending 31-Mar-2024. Show More

          • Executives

          • Auditors

          • HK

            Habil Khorakiwala

            Founder Chairman
            MK

            Murtaza Khorakiwala

            Managing Director
            HK

            Huzaifa Khorakiwala

            Executive Director
            ZK

            Zahabiya Khorakiwala

            Non Executive Director
            Show More
          • B S R & Co. LLP

          Industry

          Pharma - Indian

          Key Indices Listed on

          Nifty 500, BSE SmallCap, BSE Healthcare, + 10 more

          Address

          D-4, MIDC,Chikalthana,Aurangabad, Maharashtra - 431006

          Contact

          [email protected]

          http://www.wockhardt.com

          More Details

          FAQs about Wockhardt share

          • 1. What's the Wockhardt share price today?
            Wockhardt share price is Rs 1,270.00 as on 12 May, 2025, 03:59 PM IST. Wockhardt share price is up by 3.74% based on previous share price of Rs. 1235.2. In last 1 Month, Wockhardt share price moved down by 3.73%.
          • 2. Which are the key peers to Wockhardt?
            Top 10 Peers for Wockhardt are J B Chemicals & Pharmaceuticals Ltd., Gland Pharma Ltd., Concord Biotech Ltd., Emcure Pharmaceuticals Ltd., Suven Pharmaceuticals Ltd., Natco Pharma Ltd., Syngene International Ltd., Piramal Pharma Ltd., Ajanta Pharma Ltd. and Eris Lifesciences Ltd.
          • 3. What dividend is Wockhardt giving?
            An equity Interim dividend of Rs 10 per share was declared by Wockhardt Ltd. on 28 Oct 2016. So, company has declared a dividend of 200% on face value of Rs 5 per share. The ex dividend date was 17 Nov 2016.
          • 4. What is Wockhardt's 52 week high / low?
            Wockhardt share price saw a 52 week high of Rs 1,679.90 and 52 week low of Rs 490.15.
          • 5. Who is the chairman of Wockhardt?
            Habil Khorakiwala is the Founder Chairman of Wockhardt
          • 6. What is the CAGR of Wockhardt?
            The CAGR of Wockhardt is 0.82.
          • 7. What is the PE & PB ratio of Wockhardt?
            The PE ratio of Wockhardt stands at -104.15, while the PB ratio is 5.15.
          • 8. Who's the owner of Wockhardt?
            Following are the key changes to Wockhardt shareholding:
            • Promoter holding have gone down from 51.99 (30 Jun 2024) to 49.09 (31 Mar 2025)
            • Domestic Institutional Investors holding has gone up from 4.45 (30 Jun 2024) to 10.57 (31 Mar 2025)
            • Foreign Institutional Investors holding has gone up from 5.93 (30 Jun 2024) to 6.82 (31 Mar 2025)
            • Other investor holding have gone down from 37.62 (30 Jun 2024) to 33.51 (31 Mar 2025)
          • 9. What are the Wockhardt quarterly results?
            Total Revenue and Earning for Wockhardt for the year ending 2024-03-31 was Rs 2881.00 Cr and Rs -463.00 Cr on Consolidated basis. Last Quarter 2024-12-31, Wockhardt reported an income of Rs 729.00 Cr and profit of Rs 14.00 Cr.
          • 10. What are the returns for Wockhardt share?
            Return Performance of Wockhardt Shares:
            • 1 Week: Wockhardt share price moved down by 1.92%
            • 1 Month: Wockhardt share price moved down by 3.73%
          • 11. What are the key metrics to analyse Wockhardt Share Price?
            Wockhardt share can be quickly analyzed on following metrics:
            • Stock's PE is -108.04
            • Price to Book Ratio of 5.43
          • 12. What's the market capitalization of Wockhardt?
            Market Capitalization of Wockhardt stock is Rs 20,712.04 Cr.

          Trending in Markets

          Top Gainers As on 03:58 PM | 12 May 2025

          Cera Sanitary6,614.50
          782.50 (13.42%)
          Syrma SGS Technology541.70
          63.26 (13.22%)
          JBM Auto691.75
          71.00 (11.44%)
          RVNL359.45
          36.35 (11.26%)
          Commercial Engg370.10
          35.81 (10.71%)

          Top Losers As on 03:58 PM | 12 May 2025

          KPR Mill1,181.75
          -124.50 (-9.54%)
          Jyothy Labs350.80
          -15.90 (-4.34%)
          IndusInd Bank788.50
          -29.71 (-3.63%)
          Navin Fluorine4,433.10
          -162.00 (-3.53%)
          Eris Lifesciences1,404.90
          -51.10 (-3.51%)

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Wockhardt Share Price
          The Economic Times
          BrowseCompanies:
          OSZAR »